Pembrolizumab in Treating Patients With Advanced Uveal Melanoma

Clinical trial NCT02359851 · TERMINATED

Trial details

NCT number: NCT02359851
Sponsor: Vanderbilt-Ingram Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IIIA Uveal Melanoma Stage IIIB Uveal Melanoma Stage IIIC Uveal Melanoma Stage IV Uveal Melanoma

Start date: 2015-05-01
Primary completion: 2017-05-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.